Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The perimenopause, depressive disorders, and hormonal variability.

C N Soares1, L S Cohen

  • 1Perinatal and Reproductive Psychiatry Clinical Research Program, Center for Women's Mental Health, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA. csoares@partners.org

Sao Paulo Medical Journal = Revista Paulista De Medicina
|March 29, 2001
PubMed
Summary

Perimenopause increases vulnerability to mood disorders due to hormonal changes. Estrogen shows potential in treating perimenopausal depression, offering therapeutic options for women.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Methodological approaches to situational analysis in global mental health: a scoping review.

Global mental health (Cambridge, England)·2019
Same author

Managing the risks of mood symptoms with LNG-IUS: a clinical perspective.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception·2018
Same author

Zika virus and Guillain-Barré syndrome.

The journal of the Royal College of Physicians of Edinburgh·2016
Same author

Abnormal tau induces cognitive impairment through two different mechanisms: synaptic dysfunction and neuronal loss.

Scientific reports·2016
Same author

Maternal depression is associated with DNA methylation changes in cord blood T lymphocytes and adult hippocampi.

Translational psychiatry·2015
Same author

Comparative NMR analysis of an 80-residue G protein-coupled receptor fragment in two membrane mimetic environments.

Biochimica et biophysica acta·2011

Area of Science:

  • Reproductive Endocrinology
  • Psychiatry
  • Women's Health

Background:

  • Perimenopause is linked to increased psychiatric vulnerability, especially mood disorders.
  • Biological and psychosocial factors influence perimenopausal mood disturbances.
  • Hormonal variability during perimenopause may heighten susceptibility to mood issues.

Purpose of the Study:

  • To review perimenopause characteristics, clinical manifestations, and prevalence of depressive symptoms.
  • To discuss the heightened vulnerability to mood disturbance during perimenopause.
  • To present a therapeutic algorithm for managing depressive symptoms and review estrogen's role in treatment.

Main Methods:

  • Narrative review of clinic-based and community-based studies.

Related Experiment Videos

  • Critical review of research on depressive symptoms in perimenopausal women.
  • Analysis of existing data on estrogen's efficacy as an antidepressant.

    • Main Results:

    • Perimenopause presents unique challenges for mental health, particularly mood regulation.
    • Estrogen therapy is explored for its potential antidepressant effects in perimenopausal women.
    • Hormonal fluctuations are a key factor in perimenopausal mood disorders.

    Conclusions:

    • Perimenopause is a critical period for mood disorder vulnerability.
    • Estrogen may serve as a monotherapy, augmentation, or prophylactic treatment for perimenopausal depression.
    • A structured approach to managing perimenopausal depressive symptoms is essential.